Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
908.10
-8.15
(-0.89%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma’s marketing partner gets approval for Carfilzomib Vials
>>
Natco Pharma zooms on starting Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment
>>
Natco Pharma’s marketing partner receives final approval for Everolimus tablets
>>
Natco Pharma receives USFDA approval for Lenalidomide Capsules
>>
Natco Pharma informs about press release
>>
Natco Pharma starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment
>>
Natco Pharma informs about compliance report
>>
Natco Pharma gains on signing voluntary licensing agreement with Lilly for Baricitinib for Covid-19 in India
>>
Natco Pharma signs voluntary licensing agreement with Lilly for Baricitinib for Covid-19 in India
>>
Natco Pharma informs about press release
<<
<
19
20
21
...52
>
>>